BELVIN MARCIA bought CTMX
January 18, 2024 · Form 4 insider transaction
BELVIN MARCIA bought 26,250 shares of CytomX Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
26,250
Price
$0.00
Total value
N/A
InsiderBELVIN MARCIA
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 18, 2024
Filing dateJanuary 19, 2024
Shares owned after181,374
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3rd of the RSUs vest annually on March 15 of each year, with the first 1/3rd vesting on March 15, 2025, subject to the Reporting Person continuing as a service provider through each such date.; Includes 143,125 RSUs.